Abstract
Aim: The aim of this study was to evaluate the relationship between Interleukin-6 (IL-6) serum level and the severity and activity of Rheumatoid Arthritis (RA).
Methods: In this cross-sectional study, 120 RA patients referred to the rheumatology clinic, the patients were diagnosed by rheumatologists according to ACR / EULAR 2010 criteria. Based on DAS28 score the patients were divided into 4 groups: Remission, Mild, Moderate and Severe. Each group contained 30 patients. Serum levels of Erythrocyte Sedimentation Rate (ESR), C-Reactive Protein (CRP), anti-Cyclic Citrullinated Peptide (anti-CCP) and Rheumatoid Factor (RF) and serum levels of IL-6, were measured. The relationship between these factors was measured and compared to the relationship between IL-6 and these factors, and the activity of the disease was evaluated based on DAS-28.
Results: This study showed that the serum level of IL-6 has a significant relationship with RA activity according to DAS-28 (P value <0.001). There is also a significant relationship between the ESR level, the number of painful joints, and the number of swollen joints, and the severity of the disease based on VAS.
Conclusion: Generally the findings of this study indicate that serum level of IL-6 plays an important role in the severity and activity of RA disease and can be considered as a determining factor in evaluating the severity of RA in RA patients and it is a good guide for a step up or down of treatment.
Keywords: Interleukin 6, rheumatoid arthritis, cytokine, DAS-28, cardiomyocytes, glycoprotein.
Graphical Abstract
[http://dx.doi.org/10.1007/s11515-017-1452-4]
[http://dx.doi.org/10.1016/j.rdc.2006.07.002] [PMID: 17288969]
[http://dx.doi.org/10.1136/ard.62.7.617] [PMID: 12810422]
[PMID: 30019648]
[http://dx.doi.org/10.1016/j.ijcard.2018.07.087] [PMID: 30054148]
[http://dx.doi.org/10.2174/1381612821666150310143332] [PMID: 25760299]
[http://dx.doi.org/10.1186/ar565] [PMID: 12110143]
[http://dx.doi.org/10.1002/art.22175] [PMID: 17075861]
[http://dx.doi.org/10.1007/s00296-012-2375-7] [PMID: 22531887]
[http://dx.doi.org/10.3349/ymj.2011.52.1.113] [PMID: 21155043]
[http://dx.doi.org/10.1158/2326-6066.CIR-14-0022] [PMID: 24764575]
[http://dx.doi.org/10.1093/intimm/dxu081] [PMID: 25142313]
[http://dx.doi.org/10.1080/14397595.2017.1370766] [PMID: 28880691]
[http://dx.doi.org/10.1007/s00467-007-0670-4] [PMID: 18040727]
[http://dx.doi.org/10.1038/sj.ki.5002076] [PMID: 17228365]
[http://dx.doi.org/10.1086/514062] [PMID: 9237710]
[http://dx.doi.org/10.1016/j.aller.2013.11.003] [PMID: 24656623]
[http://dx.doi.org/10.1002/acr.22513] [PMID: 25384758]
[http://dx.doi.org/10.1177/1759720X10378372] [PMID: 22870451]
[http://dx.doi.org/10.1155/2014/698313]
[http://dx.doi.org/10.1016/j.ejr.2012.11.002]